Form 4: Sotera Health CEO Alton Shader Receives Equity Grant
Statement of Changes in Beneficial Ownership
Sotera Health CEO Alton Shader was granted 579,573 restricted stock units and 101,817 performance-based share appreciation units.
Summary
- CEO Alton Shader received a grant of 375,939 RSUs and 203,634 RSUs on May 26, 2026.
- The CEO also received 101,817 performance-based share appreciation units (SAUs).
- All equity grants were issued under the Sotera Health Company 2020 Incentive Plan.
- The RSUs and SAUs are subject to vesting conditions, beginning March 2, 2027, over a three-year period.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding executive compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of executive compensation with long-term shareholder value through equity-based incentives.
- Performance-based SAUs ensure executive rewards are tied to stock price appreciation.
Negatives
- Potential for future shareholder dilution upon the vesting and issuance of the underlying common stock.
Risks
- Vesting of equity is subject to continued employment and specific performance conditions.
- Performance-based SAUs may not vest if stock price targets are not met.
Future Outlook
The equity grants are structured to vest annually over three years starting in 2027, indicating a long-term retention and performance incentive strategy for the CEO.
Management Comments
- The grants are issued pursuant to the terms of the 2020 Incentive Plan.
Industry Context
StockSavvy.ai notes that large equity grants to CEOs in the healthcare services sector are standard practice for aligning leadership interests with long-term corporate performance and retention.
Comparison to Industry Standards
- The use of a three-year annual vesting schedule is consistent with standard corporate governance practices for executive compensation in the U.S. healthcare sector.
- Performance-based units (SAUs) are increasingly common among mid-to-large cap companies to ensure pay-for-performance alignment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of RSUs and SAUs to the CEO under the 2020 Incentive Plan. | 05/26/2026 | Standard executive compensation adjustment. |
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual settlement of these equity awards.
Next Steps
- Vesting of the first tranche of RSUs and SAUs on March 2, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/26/2026 | Date of equity grant transaction. |
| 05/27/2026 | Filing date of the Form 4. |
| 03/02/2027 | Commencement of annual vesting for RSUs and SAUs. |
Keywords
Sotera Health, SHC, Executive Compensation, Form 4, Insider Trading, Equity Grant, Alton Shader
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.